Altiratinib blocks Toxoplasma gondii and Plasmodium falciparum development by selectively targeting a kinase critical for splicing.
                                                                Swale C@, Bellini V, Matthew W. Bowler, Nardella Flore, Marie-Pierre Brenier-Pinchart, Dominique Cannella,  Lucid Belmudes,…
                                
                                    Science Translational Medicine 2022 These authors contributed equally: Christopher Swale, Bellini Valeria